Trial Profile
Probability of relapse in patients suffering with schizophrenia and treated with long acting paliperidone or oral atypical antipsychotic (OAT) in CBHO setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- 20 Aug 2015 New trial record